AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Evaluating New Alzheimer's Drugs: Efficacy and Risks
This chapter explores the effectiveness of Lakanumab and Dananimab in treating Alzheimer's by targeting beta amyloid and their impact on symptom progression. It also covers the differing administration schedules and potential serious side effects of both medications.